They are not medicines, not supplements, and not for human consumption
Concerns the FDA has flagged for this category generally - not specific to VivioMD - include: Dosing errors and confusion between milliliters, milligrams, and units in compounded injectable semaglutide Products sold as "semaglutide" that may actually contain salt forms such as semaglutide sodium or semaglutide acetate, which differ from the FDA-approved active ingredient and haven't been evaluated for safety or effectiveness Improper storage and shipping conditions for compounded injectables Fraudulent labels and doses beyond approved-label schedules Underreported adverse events across the compounded-GLP-1 category The FDA recommends that compounded drugs be used only for patients whose medical needs cannot be met by an FDA-approved drug - not as a default lower-cost substitute
PROFESSIONAL QUALITY ASSURANCE - Our GHK-Cu peptide is a cosmetic-grade ingredient suitable for creating skincare, hair care, and beauty products, ensuring consistent performance when used as directed
Nobody could have
GLP-1 Based Combination Therapy for Obesity and Diabetes
Multiple provider types can prescribe Ozempic, including primary care physicians, endocrinologists, obesity medicine specialists, and telehealth providers
